Skip to main content

MoneyWorks4Me

Ambalal Sarabhai Enterprises board to consider unaudited financial results

03 Feb 2017 Evaluate

Ambalal Sarabhai Enterprises has informed that the meeting of the Board of Directors of the Company will be held on February 09, 2017, to consider and take on record the unaudited financial results of the Company together with Limited Review Report for the quarter ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1825.35
Dr. Reddys Labs. 1360.80
Cipla 1401.75
Lupin 1987.50
Zydus Lifesciences 1196.40
View more..